Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
18.13
-0.25 (-1.36%)
At close: Jul 10, 2026, 4:00 PM EDT
18.25
+0.12 (0.66%)
After-hours: Jul 10, 2026, 5:18 PM EDT
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $1.11 billion as of July 10, 2026. Its market cap has increased by 138.39% in one year.
Market Cap
1.11B
Enterprise Value
764.73M
1-Year Change
138.39%
Ranking
Category
Stock Price
$18.13
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has increased from $829.45M to $1.11B, an increase of 34.33%. That is a compound annual growth rate of 5.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.11B | 82.23% |
| Dec 31, 2025 | 611.44M | -13.79% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 1.20B |
| Xencor | 1.18B |
| Seaport Therapeutics | 1.16B |
| Sana Biotechnology | 1.15B |
| Alpha Tau Medical | 1.15B |
| ORIC Pharmaceuticals | 1.12B |
| Forte Biosciences | 1.07B |
| Olema Pharmaceuticals | 1.04B |